Burkitt Lymphoma News and Research

RSS
Burkitt Lymphoma is an aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, bowel, kidneys, ovaries, or other organs. There are three main types of Burkitt lymphoma (sporadic, endemic, and immunodeficiency related). Sporadic Burkitt lymphoma occurs throughout the world, and endemic Burkitt lymphoma occurs in Africa. Immunodeficiency-related Burkitt lymphoma is most often seen in AIDS patients.
Efficacy of polymeric nano-micelles depends on expression level of c-Myc

Efficacy of polymeric nano-micelles depends on expression level of c-Myc

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors

Study provides insight into lymphomagenesis and patterns of resistance to immunotherapy

Study provides insight into lymphomagenesis and patterns of resistance to immunotherapy

Kids with silent malaria remain vulnerable to developing endemic Burkitt lymphoma

Kids with silent malaria remain vulnerable to developing endemic Burkitt lymphoma

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Large doses of traditional chemotherapy drug spur immune system attack on cancer cells

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

Johns Hopkins researchers uncover role of neurotransmitter in the spread of aggressive cancers

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

Scientists identify potential therapeutic target for aggressive lymphomas

Scientists identify potential therapeutic target for aggressive lymphomas

University of Glasgow-led study could lead to improved treatments for lymphoma, other cancers

University of Glasgow-led study could lead to improved treatments for lymphoma, other cancers

Researchers help explain how malaria infection increases children's risk of developing Burkitt's lymphoma

Researchers help explain how malaria infection increases children's risk of developing Burkitt's lymphoma

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Melbourne researchers develop new genome editing technology to kill blood cancer cells

Melbourne researchers develop new genome editing technology to kill blood cancer cells

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patrys provides update on development programme for anti-cancer product, PAT-LM1

Patrys provides update on development programme for anti-cancer product, PAT-LM1

Study: Immune-regulating molecules can trigger lymphomas

Study: Immune-regulating molecules can trigger lymphomas

Researchers discover promising new way to treat HIV-related blood cancer

Researchers discover promising new way to treat HIV-related blood cancer

Burkitt lymphoma risk after transplantation highlighted

Burkitt lymphoma risk after transplantation highlighted

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies